Navigation Links
Cell death research wins professor Andreas Strasser 2011 Victoria Prize
Date:11/14/2011

Professor Andreas Strasser from the Walter and Eliza Hall Institute of Medical Research has been awarded the 2011 Victoria Prize for his research into the control of cell death.

The $50,000 Victoria Prize is awarded annually by the Victorian Government to a scientist whose discovery has significantly advanced knowledge.

Programmed cell death, or apoptosis, is an important biological process that removes unwanted or defective cells in humans and animals. Professor Strasser's research into the control of cell death has shown that defects in cell death can lead to the development of cancer or autoimmune disease (where the immune system mistakenly attacks and destroys healthy body tissue), and render cancer cells resistant to chemotherapeutics.

Born and educated in Switzerland, Professor Strasser has worked at the Walter and Eliza Hall Institute since 1989. He is now the joint head, with Professor Jerry Adams, of the institute's Molecular Genetics of Cancer division. His current research interests include the regulation of cell death in blood cells and cancer cells, and how anti-cancer treatments can be improved by increasing cancer cells' propensity to die.

Professor Strasser said he was honoured to receive the Victoria Prize. "I have been fortunate in my research career to have been surrounded by many outstanding scientists," he said. "I am particularly grateful to have been mentored by Suzanne Cory, Jerry Adams and Alan Harris. With David Vaux, they laid the critical groundwork in cell death and cancer research that I was able to build upon. I have also been fortunate to have been surrounded by many outstanding laboratory members, and had many fruitful collaborations with other institute researchers, such as Philippe Bouillet and David Huang."

Professor David Vaux, head of the institute's Cell Signalling and Cell Death division, said Professor Strasser had made many significant discoveries into the control of cell death. "In the 22 years that I have collaborated with Andreas, cell death research has grown from small beginnings into a huge field that is important in many areas of medical research," Professor Vaux said. "Andreas can take credit for driving many advances during this time. He discovered key molecules that regulate cell death in mammals, and was the very first to establish the link between defects in cell death and autoimmunity."

Professor Strasser is the institute's fourth Victoria Prize winner since the prize's inception in 1998. Previous winners have included Professor Don Metcalf (2000) from the institute's Cancer and Haematology division, Professor Vaux (2003) and Professor Peter Colman (2008), head of the institute's Structural Biology division.

The director of the Walter and Eliza Hall Institute, Professor Doug Hilton, said Professor Strasser had made a huge contribution to medical research. "Andreas is held in immense regard by his peers," Professor Hilton said. "He is a very deserving winner of Victoria's highest prize for science and technology."

Professor Strasser has received many awards recognising his scientific achievements, including the Friedrich Miescher Prize from the Swiss Society for Biochemistry, the Dr Josef Steiner Cancer Research Prize and the Glaxo Wellcome Australia Prize, which he shared with Professor Vaux.

The Minister for Innovation, Services and Small Business, the Hon. Ms Louise Asher MLA, today presented Professor Strasser with the Victoria Prize. The Walter and Eliza Hall Institute will receive the $100,000 Anne & Eric Smorgon Memorial Award, provided by the Jack and Robert Smorgon Families Foundation to the Victoria Prize winner's organisation.


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related medicine news :

1. Experimental Drug for Irregular Heart Rhythm Raises Death Risk: Study
2. Sepsis Plus Heart Rhythm Disorder Linked to Stroke, Death
3. Wearable defibrillator can prevent death in people with arrhythmias
4. Few doctors follow sudden cardiac death screening guidelines for athletes
5. Lancet pneumonia study offers new hope for reducing No. 1 cause of child death
6. NYU Langone expert calls for awareness, research of sudden death in patients with epilepsy
7. Death Toll From Listeria Outbreak Hits 29
8. Deaths From Abuse of Painkillers Triple in a Decade: CDC
9. Research supports broader screening for sudden cardiac death
10. Team discovers how a cancer-causing bacterium spurs cell death
11. IHME develops fast, affordable ways for countries to better identify causes of death in populations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cell death research wins professor Andreas Strasser 2011 Victoria Prize
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: